Conquering Diseases

A Study Of An Investigational Drug In Recurrent Ovarian Cancer

Description

Seeking women 18 years or older with confirmed ovarian cancer who have previously received treatment, for participation in a study of an investigational drug for subjects with recurrent ovarian cancer that has failed previous treatment

Overview

We are studying the effects of an investigatory drug called Pembrolizumab or placebo, in combination other standard of care drugs for participants with recurrent ovarian cancer to determine how safe it is and how well it works for this type of cancer. Evaluate the safety of Pembrolizumab compared to the standard of care in participants with recurrent ovarian cancer.

What we're hoping for

Evaluate the safety of Pembrolizumab and how well it works compared to the standard of care in participants with recurrent ovarian cancer.

Additional Information

ClinicalTrials.gov Identifier: NCT05116189

 Principal Investigator

Susan  Zweizig, MD

UMass Memorial Health Care

 Study Contact

The Cancer  Research Office

508-856-3216

Cancer.research@umassmed.edu

 Location

UMMS University Campus

55 Lake Ave North 

Worcester,MA 01655

508-856-8989